0001609251-23-000005.txt : 20231115 0001609251-23-000005.hdr.sgml : 20231115 20231114201557 ACCESSION NUMBER: 0001609251-23-000005 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231115 DATE AS OF CHANGE: 20231114 EFFECTIVENESS DATE: 20231115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Krensavage Asset Management, LLC CENTRAL INDEX KEY: 0001609251 IRS NUMBER: 262520930 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16807 FILM NUMBER: 231408779 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 212-888-1582 MAIL ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false false false 0001609251 XXXXXXXX 09-30-2023 09-30-2023 Krensavage Asset Management, LLC

610 FIFTH AVENUE SUITE 301 NEW YORK NY 10020

13F HOLDINGS REPORT 028-16807 N Paul J. Paolino 212-518-3193 /s/ Paul J. Paolino New York NY 11-14-2023 0 12 271606 false INFORMATION TABLE 2 krensavage13f09302023.xml KRENSAVAGE FORM 13F 09.30.2023 ALKERMES PLC COM G01767105 25379 906060 SH SOLE 906060 0 0 BIOGEN INC COM 09062X103 41245 160480 SH SOLE 160480 0 0 CARDINAL HEALTH INC COM 14149Y108 25292 291319 SH SOLE 291319 0 0 EAGLE PHARMACEUTICALS INC COM 269796108 1777 112666 SH SOLE 112666 0 0 EMBECTA CORP COM 29082K105 17531 1164876 SH SOLE 1164876 0 0 ENANTA PHARMACEUTICALS INC COM 29251M106 8211 735103 SH SOLE 735103 0 0 EXELIXIS INC COM 30161Q104 41496 1899151 SH SOLE 1899151 0 0 KODIAK SCIENCES INC COM 50015M109 616 342312 SH SOLE 342312 0 0 REGENERON PHARMACEUTICALS COM 75886F107 38890 47256 SH SOLE 47256 0 0 TARO PHARMACEUTICAL INDUS COM M8737E108 24162 640735 SH SOLE 640735 0 0 UNITED THERAPEUTICS CORP COM 91307C102 45450 201222 SH SOLE 201222 0 0 VANDA PHARMACEUTICALS INC COM 921659108 1557 360429 SH SOLE 360429 0 0